Tafamidis
Products Tafamidis was approved in the EU in 2011, in the US in 2019, and in many countries in 2020 in soft capsule form (Vyndaqel). Structure and properties Tafamidis (C14H7Cl2NO3, Mr = 308.1 g/mol) is present in the drug either as tafamidis meglumine or as tafamidis. Effects Tafamidis (ATC N07XX08) is a selective stabilizer of … Tafamidis